Restricted Mean Survival Time as a Measure to Interpret Clinical Trial Results-Reference-Cited by-同舟云学术

Restricted Mean Survival Time as a Measure to Interpret Clinical Trial Results

Published:2017-11-01 Issue:11 Volume:2 Page:1179
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Kim Dae Hyun¹,Uno Hajime²,Wei Lee-Jen³

Affiliation:

1. Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts2Division of Gerontology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts

2. Division of Population Sciences, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts

3. Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hazard Ratios and Alternative Effect Measures: An Applied Illustration;Pharmacoepidemiology and Drug Safety;2024-08-30

2. Semiparametric Additive Modeling of the Restricted Mean Survival Time;Biometrical Journal;2024-08-16

3. The recombinant shingles vaccine is associated with lower risk of dementia;Nature Medicine;2024-07-25

4. Prognosis based on postoperative PSA levels and treatment in prostate cancer with lymph node involvement;International Journal of Clinical Oncology;2024-07-08

5. Evaluation of Overall Survival by Restricted Mean Survival Time of Advanced Biliary Tract Cancer treated with Immunotherapy: A Systematic Review and Meta-Analysis;Cancers;2024-05-30